Clinical Trial Update: Field Randomization of Nerinetide (NA-1) Therapy in Early Responders [Phase 3]

View source ↗

Summary

Phase 3 trial update on nerinetide (NA-1) in early responders for acute cerebral ischemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Ischemia

Drugs mentioned

• nerinetide (NA-1) (nerinetide)

Snippet

Sponsor: NoNO Inc. | Conditions: Acute Cerebral Ischemia | Phase 3 | Status: COMPLETED